Performance of drug-coated balloons in coronary and below-the-knee arteries: Anatomical, physiological and pathological considerations
Vascul Pharmacol. 2024 Mar 11:107366. doi: 10.1016/j.vph.2024.107366. Online ahead of print.ABSTRACTBelow-the-knee (infrapopliteal) atherosclerotic disease, which presents as chronic limb-threatening ischemia (CLTI) in nearly 50% of patients, represents a treatment challenge when it comes to the endovascular intervention arm of management. Due to reduced tissue perfusion, patients usually experience pain at rest and atrophic changes correlated to the extent of the compromised perfusion. Unfortunately, the prognosis remains unsatisfactory with 30% of patients requiring major amputation and a mortality rate of 25% within 1 y...
Source: Vascular Pharmacology - March 13, 2024 Category: Drugs & Pharmacology Authors: Rafic Ramses Simon Kennedy Richard Good Keith G Oldroyd Sean Mcginty Source Type: research
Comparison of the Pre-Established and Finally Selected Treatment Strategies for Endovascular Treatment in Femoropopliteal Artery Lesions
This study aimed to compare lower limb events associated with preplanned and finally selected treatment strategies-the validity and usefulness of the physician-chosen strategy were verified.We examined the data of 1003 patients in the registry of multicenter endovascular treatment for superficial femoral and popliteal artery disease study and prospectively enrolled patients who underwent endovascular treatment (EVT) of the femoropopliteal (FP) artery between February 2017 and June 2018 from 67 Japanese institutes. The outcome measures were major adverse limb events (MALE) and target vessel revascularization.The EVT strateg...
Source: International Heart Journal - March 13, 2024 Category: Cardiology Authors: Michiaki Higashitani Daisuke Ueshima Kenji Suzuki Yasutaka Yamauchi Mitsugu Hirokami Yoshinori Tsubakimoto Akihiko Takahashi Taku Kato Hiroshi Ando Masato Nakamura Source Type: research
Performance of drug-coated balloons in coronary and below-the-knee arteries: Anatomical, physiological and pathological considerations
Vascul Pharmacol. 2024 Mar 11:107366. doi: 10.1016/j.vph.2024.107366. Online ahead of print.ABSTRACTBelow-the-knee (infrapopliteal) atherosclerotic disease, which presents as chronic limb-threatening ischemia (CLTI) in nearly 50% of patients, represents a treatment challenge when it comes to the endovascular intervention arm of management. Due to reduced tissue perfusion, patients usually experience pain at rest and atrophic changes correlated to the extent of the compromised perfusion. Unfortunately, the prognosis remains unsatisfactory with 30% of patients requiring major amputation and a mortality rate of 25% within 1 y...
Source: Vascular Pharmacology - March 13, 2024 Category: Drugs & Pharmacology Authors: Rafic Ramses Simon Kennedy Richard Good Keith G Oldroyd Sean Mcginty Source Type: research
Comparison of the Pre-Established and Finally Selected Treatment Strategies for Endovascular Treatment in Femoropopliteal Artery Lesions
This study aimed to compare lower limb events associated with preplanned and finally selected treatment strategies-the validity and usefulness of the physician-chosen strategy were verified.We examined the data of 1003 patients in the registry of multicenter endovascular treatment for superficial femoral and popliteal artery disease study and prospectively enrolled patients who underwent endovascular treatment (EVT) of the femoropopliteal (FP) artery between February 2017 and June 2018 from 67 Japanese institutes. The outcome measures were major adverse limb events (MALE) and target vessel revascularization.The EVT strateg...
Source: International Heart Journal - March 13, 2024 Category: Cardiology Authors: Michiaki Higashitani Daisuke Ueshima Kenji Suzuki Yasutaka Yamauchi Mitsugu Hirokami Yoshinori Tsubakimoto Akihiko Takahashi Taku Kato Hiroshi Ando Masato Nakamura Source Type: research
Performance of drug-coated balloons in coronary and below-the-knee arteries: Anatomical, physiological and pathological considerations
Vascul Pharmacol. 2024 Mar 11:107366. doi: 10.1016/j.vph.2024.107366. Online ahead of print.ABSTRACTBelow-the-knee (infrapopliteal) atherosclerotic disease, which presents as chronic limb-threatening ischemia (CLTI) in nearly 50% of patients, represents a treatment challenge when it comes to the endovascular intervention arm of management. Due to reduced tissue perfusion, patients usually experience pain at rest and atrophic changes correlated to the extent of the compromised perfusion. Unfortunately, the prognosis remains unsatisfactory with 30% of patients requiring major amputation and a mortality rate of 25% within 1 y...
Source: Vascular Pharmacology - March 13, 2024 Category: Drugs & Pharmacology Authors: Rafic Ramses Simon Kennedy Richard Good Keith G Oldroyd Sean Mcginty Source Type: research
Comparison of the Pre-Established and Finally Selected Treatment Strategies for Endovascular Treatment in Femoropopliteal Artery Lesions
This study aimed to compare lower limb events associated with preplanned and finally selected treatment strategies-the validity and usefulness of the physician-chosen strategy were verified.We examined the data of 1003 patients in the registry of multicenter endovascular treatment for superficial femoral and popliteal artery disease study and prospectively enrolled patients who underwent endovascular treatment (EVT) of the femoropopliteal (FP) artery between February 2017 and June 2018 from 67 Japanese institutes. The outcome measures were major adverse limb events (MALE) and target vessel revascularization.The EVT strateg...
Source: International Heart Journal - March 13, 2024 Category: Cardiology Authors: Michiaki Higashitani Daisuke Ueshima Kenji Suzuki Yasutaka Yamauchi Mitsugu Hirokami Yoshinori Tsubakimoto Akihiko Takahashi Taku Kato Hiroshi Ando Masato Nakamura Source Type: research
Performance of drug-coated balloons in coronary and below-the-knee arteries: Anatomical, physiological and pathological considerations
Vascul Pharmacol. 2024 Mar 11:107366. doi: 10.1016/j.vph.2024.107366. Online ahead of print.ABSTRACTBelow-the-knee (infrapopliteal) atherosclerotic disease, which presents as chronic limb-threatening ischemia (CLTI) in nearly 50% of patients, represents a treatment challenge when it comes to the endovascular intervention arm of management. Due to reduced tissue perfusion, patients usually experience pain at rest and atrophic changes correlated to the extent of the compromised perfusion. Unfortunately, the prognosis remains unsatisfactory with 30% of patients requiring major amputation and a mortality rate of 25% within 1 y...
Source: Vascular Pharmacology - March 13, 2024 Category: Drugs & Pharmacology Authors: Rafic Ramses Simon Kennedy Richard Good Keith G Oldroyd Sean Mcginty Source Type: research
Comparison of the Pre-Established and Finally Selected Treatment Strategies for Endovascular Treatment in Femoropopliteal Artery Lesions
This study aimed to compare lower limb events associated with preplanned and finally selected treatment strategies-the validity and usefulness of the physician-chosen strategy were verified.We examined the data of 1003 patients in the registry of multicenter endovascular treatment for superficial femoral and popliteal artery disease study and prospectively enrolled patients who underwent endovascular treatment (EVT) of the femoropopliteal (FP) artery between February 2017 and June 2018 from 67 Japanese institutes. The outcome measures were major adverse limb events (MALE) and target vessel revascularization.The EVT strateg...
Source: International Heart Journal - March 13, 2024 Category: Cardiology Authors: Michiaki Higashitani Daisuke Ueshima Kenji Suzuki Yasutaka Yamauchi Mitsugu Hirokami Yoshinori Tsubakimoto Akihiko Takahashi Taku Kato Hiroshi Ando Masato Nakamura Source Type: research
Performance of drug-coated balloons in coronary and below-the-knee arteries: Anatomical, physiological and pathological considerations
Vascul Pharmacol. 2024 Mar 11:107366. doi: 10.1016/j.vph.2024.107366. Online ahead of print.ABSTRACTBelow-the-knee (infrapopliteal) atherosclerotic disease, which presents as chronic limb-threatening ischemia (CLTI) in nearly 50% of patients, represents a treatment challenge when it comes to the endovascular intervention arm of management. Due to reduced tissue perfusion, patients usually experience pain at rest and atrophic changes correlated to the extent of the compromised perfusion. Unfortunately, the prognosis remains unsatisfactory with 30% of patients requiring major amputation and a mortality rate of 25% within 1 y...
Source: Vascular Pharmacology - March 13, 2024 Category: Drugs & Pharmacology Authors: Rafic Ramses Simon Kennedy Richard Good Keith G Oldroyd Sean Mcginty Source Type: research
Comparison of the Pre-Established and Finally Selected Treatment Strategies for Endovascular Treatment in Femoropopliteal Artery Lesions
This study aimed to compare lower limb events associated with preplanned and finally selected treatment strategies-the validity and usefulness of the physician-chosen strategy were verified.We examined the data of 1003 patients in the registry of multicenter endovascular treatment for superficial femoral and popliteal artery disease study and prospectively enrolled patients who underwent endovascular treatment (EVT) of the femoropopliteal (FP) artery between February 2017 and June 2018 from 67 Japanese institutes. The outcome measures were major adverse limb events (MALE) and target vessel revascularization.The EVT strateg...
Source: International Heart Journal - March 13, 2024 Category: Cardiology Authors: Michiaki Higashitani Daisuke Ueshima Kenji Suzuki Yasutaka Yamauchi Mitsugu Hirokami Yoshinori Tsubakimoto Akihiko Takahashi Taku Kato Hiroshi Ando Masato Nakamura Source Type: research
Performance of drug-coated balloons in coronary and below-the-knee arteries: Anatomical, physiological and pathological considerations
Vascul Pharmacol. 2024 Mar 11;155:107366. doi: 10.1016/j.vph.2024.107366. Online ahead of print.ABSTRACTBelow-the-knee (infrapopliteal) atherosclerotic disease, which presents as chronic limb-threatening ischemia (CLTI) in nearly 50% of patients, represents a treatment challenge when it comes to the endovascular intervention arm of management. Due to reduced tissue perfusion, patients usually experience pain at rest and atrophic changes correlated to the extent of the compromised perfusion. Unfortunately, the prognosis remains unsatisfactory with 30% of patients requiring major amputation and a mortality rate of 25% within...
Source: Vascular Pharmacology - March 13, 2024 Category: Drugs & Pharmacology Authors: Rafic Ramses Simon Kennedy Richard Good Keith G Oldroyd Sean Mcginty Source Type: research
Comparison of the Pre-Established and Finally Selected Treatment Strategies for Endovascular Treatment in Femoropopliteal Artery Lesions
This study aimed to compare lower limb events associated with preplanned and finally selected treatment strategies-the validity and usefulness of the physician-chosen strategy were verified.We examined the data of 1003 patients in the registry of multicenter endovascular treatment for superficial femoral and popliteal artery disease study and prospectively enrolled patients who underwent endovascular treatment (EVT) of the femoropopliteal (FP) artery between February 2017 and June 2018 from 67 Japanese institutes. The outcome measures were major adverse limb events (MALE) and target vessel revascularization.The EVT strateg...
Source: International Heart Journal - March 13, 2024 Category: Cardiology Authors: Michiaki Higashitani Daisuke Ueshima Kenji Suzuki Yasutaka Yamauchi Mitsugu Hirokami Yoshinori Tsubakimoto Akihiko Takahashi Taku Kato Hiroshi Ando Masato Nakamura Source Type: research
